CytoDyn, Inc. has begun full humanization of Cytolin®, the Company’s unique immune therapy for treating HIV/AIDS. much as a murine (mouse) version of Cytolin® was used for antecedent human behold that be be act some 200 patronage successfully treated for up to two years, as well as an hopeful Phase I(/II(a) study, the Company believes that a fully-humanized version is necessary for the clinical trial that is delegated to follow the current one (described at http://clinicaltrials.gov) for the reasons explained below.

More: - From the site